J. of Supercritical Fluids 101 (2015) 17–23
Contents lists available at ScienceDirect
The Journal of Supercritical Fluids
j our na l ho me page: www.elsevier.com/locate/supflu
Solid-state property modification and dissolution rate enhancement
of tolfenamic acid by supercritical antisolvent process
Hung-Hsin Chen
a
, Chie-Shaan Su
a,∗
, Jun-Jen Liu
b
, Ming-Thau Sheu
c,∗∗
a
Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, Taipei, Taiwan
b
School of Medical Laboratory Science and Biotechnology, Taipei Medical University, Taipei, Taiwan
c
School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan
a r t i c l e i n f o
Article history:
Received 6 October 2014
Received in revised form 25 February 2015
Accepted 25 February 2015
Available online 4 March 2015
Keywords:
Recrystallization
Supercritical antisolvent
Carbon dioxide
Tolfenamic acid
a b s t r a c t
In this study, the supercritical antisolvent (SAS) process is applied to crystallization of an active pharma-
ceutical ingredient, tolfenamic acid, using carbon dioxide as the antisolvent. Six operating parameters in
the SAS process including solvent system, operating temperature, operating pressure, solution concentra-
tion, solution flow rate and nozzle diameter are studied. The effects of operating parameters on solid-state
properties of the processed tolfenamic acid including crystal habit, mean particle size and polymorphic
form are compared and discussed. The crystal habit of original tolfenamic acid crystals is irregular shape
with Form I polymorph. The mean particle size of original powders is about 30 m. After recrystalliza-
tion using SAS process, two polymorphic forms of tolfenamic acid with different crystal habits and mean
particle sizes are obtained. Form I tolfenamic acid shows a needle-like crystal habit with mean particle
size of about 20 m; while Form II tolfenamic acid shows a rod-like crystal habit with mean particle
size of around 10 m. In addition, the dissolution profiles of original and recrystallized tolfenamic acids
are also studied and compared. Experimental results show that the recrystallized Form II tolfenamic acid
crystals has an enhanced dissolution rate compared with the original sample, demonstrating that the SAS
technology is an efficient process for controlling and modifying the solid-state properties of tolfenamic
acid and also produces microparticles with enhanced dissolution behavior.
© 2015 Elsevier B.V. All rights reserved.
1. Introduction
The solid-state properties of active pharmaceutical ingredients
(API) such as particle size, crystal habit and polymorphic form have
been shown to play critical roles in pharmaceutical industry for
controlling the dissolution rate, developing suitable administra-
tion routes, and designing the appropriate dosage form [1–3]. In
conventional API manufacturing process, the solid-state properties
of API are frequently controlled by the crystallization process and
mechanical milling. However, this conventional route has several
disadvantages including residual solvent contamination, batch-
to-batch variation and surface property destruction. Thus, in the
literature, alternative processes have been designed and developed.
Examples of such processes are supercritical fluid crystallization
∗
Corresponding author. Tel.: +886 227712171.
∗∗
Corresponding author. Tel.: +886 227361661.
E-mail addresses: cssu@ntut.edu.tw (C.-S. Su), mingsheu@tmu.edu.tw
(M.-T. Sheu).
technology, ultrasonic crystallization process and ionic liquid crys-
tallization method [4–9].
Supercritical fluid technology has been widely applied in differ-
ent fields including extraction, chromatography, chemical reaction
and material processing [10,11]. Among these applications, the
use of supercritical fluids for the recrystallization of pharmaceu-
tical compounds has been investigated by an increasing number
of research groups because of its numerous advantages [12,13].
Depending on the solubility of API in supercritical fluid, differ-
ent supercritical fluid particle formation techniques have been
developed, classified and reviewed. These techniques include rapid
expansion of supercritical solution (RESS), supercritical antisolvent
(SAS), supercritical assisted atomization (SAA) and particle from
gas saturated solution (PGSS) [14], among which SAS and RESS pro-
cesses are more widely used. In the RESS process, supercritical fluid
is used as the solvent while in the SAS process, supercritical fluid is
recognized as the antisolvent.
The SAS process is most commonly applied to processing phar-
maceutical compounds. For example, Rossmann et al. [15] used the
SAS process to manipulate the size, crystal habit and polymorphic
form of acetaminophen. The polymorph of acetaminophen crystals
http://dx.doi.org/10.1016/j.supflu.2015.02.031
0896-8446/© 2015 Elsevier B.V. All rights reserved.